iSpecimen cuts biospecimen shipping time by 85% with direct delivery model

iSpecimen (NASDAQ: ISPC) has implemented a direct shipping model that reduces biospecimen delivery times by 70-85%, the company announced. The Woburn, Massachusetts-based online marketplace for human biospecimens now enables direct shipment from supplier sites to customers, eliminating the need for centralized hub processing.

Under the previous system, shipments required routing through a central hub, adding 7-14 days to transit times. The new approach allows domestic shipments to be delivered in 1-2 days while reducing overall shipping costs through fewer handoffs.

The company has expanded its international operations by strengthening partnerships with sourcing organizations across Europe and Eastern Europe. This network expansion provides broader access to rare biospecimens while maintaining the improved delivery timelines.

"In addition to our AI agent, streamlining shipments is an example of the team's operational flexibility and expertise," said Katie Field, CEO of iSpecimen. "Since this process improvement customers have been pleased too, for example one was 'impressed with the quality and care taken...in the careful sourcing and handling of the research materials.'"

The shipping model was implemented earlier this year and has received positive customer feedback regarding delivery speed and reliability, according to the company's press release statement.

iSpecimen operates a technology platform that connects life science researchers with biospecimen suppliers globally to facilitate medical research.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Raymond James Reiterates Strong Buy Rating on Vir Biotechnology (VIR)
• Truist Securities: 'We remain buyers of IVA'